Page last updated: 2024-10-24

candesartan cilexetil and Brain Hemorrhage

candesartan cilexetil has been researched along with Brain Hemorrhage in 1 studies

candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects

Research Excerpts

ExcerptRelevanceReference
"The Challenge-Stroke study was conducted in Japanese patients initiated on candesartan cilexetil therapy within 3 months of suffering a stroke to investigate the clinical use of candesartan and its efficacy/safety in this therapeutic setting."7.77Candesartan cilexetil in the management of blood pressure for acute and recurrent stroke in Japan: the Challenge-Stroke study. ( Minematsu, K; Nakagawara, J; Okada, Y; Tanahashi, N, 2011)
"The Challenge-Stroke study was conducted in Japanese patients initiated on candesartan cilexetil therapy within 3 months of suffering a stroke to investigate the clinical use of candesartan and its efficacy/safety in this therapeutic setting."3.77Candesartan cilexetil in the management of blood pressure for acute and recurrent stroke in Japan: the Challenge-Stroke study. ( Minematsu, K; Nakagawara, J; Okada, Y; Tanahashi, N, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tanahashi, N1
Nakagawara, J1
Okada, Y1
Minematsu, K1

Other Studies

1 other study available for candesartan cilexetil and Brain Hemorrhage

ArticleYear
Candesartan cilexetil in the management of blood pressure for acute and recurrent stroke in Japan: the Challenge-Stroke study.
    Expert review of cardiovascular therapy, 2011, Volume: 9, Issue:9

    Topics: Acute Disease; Aged; Aged, 80 and over; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds;

2011